Advertisement

May 14, 2020

SCAI Issues Device Selection Guidelines for Aortoiliac Arterial Interventions

May 14, 2020—Guidelines from the Society for Cardiovascular Angiography and Interventions (SCAI) that provide a comprehensive review of comparative effectiveness data for devices used in aortoiliac arterial interventions have been published by Dmitriy N. Feldman MD, et al in Catheterization and Cardiovascular Interventions. The guidelines were presented during the SCAI 2020 Scientific Sessions Virtual Conference held online May 14–16.

According to SCAI, the recommendations aim to provide clinicians with guidance for device selection in patients with aortoiliac disease for whom these devices are intended as definitive therapy. The writing group used a modified Delphi panel methodology to form recommendations based on data extracted through a systematic review of available evidence. They graded recommendations for eleven relevant anatomic scenarios according to the strength of the recommendation (magnitude of benefit or harm, including the cost of use) and certainty of the evidence (type, quality, and consistency of data).

“Endovascular device selection in peripheral arterial interventions remains challenging due to paucity of comparative data and a wide spectrum of available devices,” commented Dr. Feldman in the announcement. He continued, “In 2018, SCAI developed the first-of-its-kind guidance document to address device selection in femoral-popliteal arterial interventions. The purpose of newly released 2020 SCAI guidelines is to provide a comprehensive review of comparative effectiveness data for aortoiliac devices and to arm clinicians with evidence-based recommendations and practical guidance for selection of devices in aortoiliac arterial interventions.”

Advertisement


May 15, 2020

Bluegrass Vascular Announces First US Surfacer Inside-Out Catheter Commercial Cases

May 14, 2020

STEM Trial Approved for Balt’s Squid Liquid Embolic Device